Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Modeling disease severity in multiple sclerosis using electronic health records.
Involvement of Toso in activation of monocytes, macrophages, and granulocytes.
The Blood-Brain Barrier in Multiple Sclerosis: MicroRNAs as Key Regulators.
Efficacy and safety of fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis (FREEDOMS II)
Female Gender and Reproductive Factors Affecting Risk, Relapses and Progression in Multiple Sclerosis.
Traumatic injury and multiple sclerosis: a systematic review and meta-analysis.
No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis.
Association of smoking with risk of multiple sclerosis: a population-based study.
Brain disorders where resources are scarce: The unfinished agenda.
Co-morbid Guillain-Barre syndrome and acute disseminated encephalomyelitis.
Conference Scene: Regulatory cells in autoimmunity: analyzing and moderating function.
Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report.
Natalizumab and the development of extensive brain lesions in neuromyelitis optica.
Disruption of Myelin Leads to Ectopic Expression of KV1.1 Channels with Abnormal Conductivity of Optic Nerve Axons in a Cuprizone-Induced Model of Demyelination.
A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis.
Neurological disorders in the Global Burden of Disease 2010 study.
Janus Faces of Amyloid Proteins in Neuroinflammation.
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs.
Self-report versus performance measure in gauging level of function with multiple sclerosis.
[Disease modifying drugs in multiple sclerosis and pregnancy.]
Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Association between vestibulo-ocular reflex suppression, balance, gait, and fall risk in ageing and neurodegenerative disease: protocol of a one-year prospective follow-up study.
Fbxw7 Limits Myelination by Inhibiting mTOR Signaling.
Effects of multiwalled carbon nanotubes on electrospun poly(lactide-co-glycolide)-based nanocomposite scaffolds on neural cells proliferation.
Pages
« first
‹ previous
…
436
437
438
439
440
441
442
443
444
…
next ›
last »